Trochleoplasty in the Management of Objective Patellar Instability: a Personalized Surgical Approach for the Prevention of Recurrence in Patients With Trochlear Dysplasia (TROCHLEO-CARE)
This is a multicentre, international, non-profit observational study aimed at prospectively validating a personalized diagnostic and therapeutic algorithm based on the Dejour v3.0 classification in patients with recurrent objective patellar instability and trochlear dysplasia.
The primary objective is to compare treatment failure rates at 24 months between patients with severe trochlear dysplasia (trochlear bump >5 mm) treated with trochleoplasty and MPFL reconstruction, and a retrospective control group with similar trochlear morphology treated without trochleoplasty.
Secondary outcomes include clinical and functional outcomes assessed using validated scores (IKDC, Kujala, Tegner and BPII 2.0), cartilage status assessed by MRI using the MOAKS score, and postoperative complications, particularly arthrofibrosis.
Patients aged 14-49 years will be enrolled at IRCCS Istituto Ortopedico Rizzoli and Lyon Ortho Clinic. The study includes both a prospective cohort managed according to the Dejour v3.0 algorithm and a retrospective historical control cohort. Follow-up assessments will be performed up to 24 months after surgery.
The study is planned to start on October 1, 2026, with an expected completion date of September 30, 2029. A total sample size of 152 patients (76 per group) is planned.
研究概览
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Stefano Zaffagnini
- 电话号码:0516366075
- 邮箱:stefano.zaffagnini@ior.it
学习地点
-
-
Bologna
-
Bologna、Bologna、意大利、40136
- IRCCS Rizzoli Orthopedic Institute
-
接触:
- Stefano Zaffagnini
- 电话号码:0516366075
- 邮箱:stefano.zaffagnini@ior.it
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
The study will be conducted within the facilities of the Orthopedic and Traumatology Clinic II Unit at the IRCCS Istituto Ortopedico Rizzoli and at the Lyon Ortho Clinic. Surgical procedures will be performed at both these institutions.
Patients will be asked to sign an informed consent during the hospital stay and after signing the informed consent will be asked to complete a questionnaire on the preoperative condition.
Clinical follow-up visits will be carried out at the outpatient clinics of the IRCCS Istituto Ortopedico Rizzoli as well as at the Lyon Ortho Clinic.
描述
Inclusion Criteria study group:
- Patients aged ≥14 years and <50 years
- Male and female patients
- Patients with a clinical history of recurrent objective patellar instability (OPI)
- Provision of written informed consent to participate in the study
- Patients who performed preoperative imaging studies (MRI) that confirmed the diagnosis and the need for treatment based on the above mentioned criteria (type 3 dysplasia with a bump >5mm)
Exclusion Criteria study group:
- Patients with established knee osteoarthritis (K-L ≥2)
- Patients with concomitant ligament injuries (including anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), or collateral ligaments)
- Patients with a history of prior knee surgery for conditions other than patellar instability
- Patients who have previously undergone surgical procedures for patellar instability (OPI)
- Patients with incomplete or inadequate MRI data
Inclusion Criteria control group:
- Patients aged ≥14 years and <50 years treated for OPI with another procedure except trochleoplasty in the two reference centres from 2022 to 2024
- Male and female patients
- Provision of written informed consent to participate in the study
- Patients who performed preoperative imaging studies (MRI/CT scan) that confirmed a type 3 dysplasia with a bump >5mm
Exclusion Criteria control group:
- Patients with concomitant ligament injuries (including anterior cruciate ligament (ACL), posterior cruciate ligament (PCL), or collateral ligaments)
- Patients with a history of prior knee surgery for conditions other than patellar instability
- Patients who have had previously undergone surgical procedures for patellar instability (OPI) at the time of the MRI/CT scan
- Patients with incomplete or inadequate MRI or CT scan data
学习计划
研究是如何设计的?
设计细节
- 观测模型:CASE_CONTROL
- 时间观点:PROSPECTIVE
队列和干预
团体/队列 |
|---|
|
Case group
Patients who performed preoperative imaging studies (MRI) that confirmed the diagnosis and the need for treatment based on the above mentioned criteria (type 3 dysplasia with a bump >5mm). They are treated according to the Dejour v3.0 algorithm, which involves trochleoplasty combined with medial patellofemoral ligament (MPFL) reconstruction. |
|
Control group
The control group includes patients with comparable anatomical characteristics who were previously treated without trochleoplasty. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Failure rates
大体时间:At 24 months
|
Defined as reoperation for subsequent atraumatic patellar luxation or persistent instability at 24 months. They will be registered in the CRF during the follow-up visits or during the telephonic contact in case of missing follow-ups. This could also be assessed through the clinical documentation of the patient, in case of missing data. |
At 24 months
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- TROCHLEO-CARE
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.